NCT07133815: Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
- State
- Not started
- Phase
- Phase 2
- People
- 55 planned
- Started
- Aug 2025
- Primary completion
- Dec 2025
- Arms
- SHR-1918
- Results
- None posted
- 21 Aug 2025: Trial registered